The Clinical and Molecular Hepatology, is an international, peer-reviewed, open- access journal published quarterly in English. The Clinical and Molecular Hepatology aims to share advanced and latest knowledge, trend, and understanding of hepatobiliary diseases, to provide a wide open academic forum for active debate and discussion among clinical doctors, translational researchers, and basic scientists, and to improve public health through a multidisciplinary approach, especially in resource-limited Asia-Pacific area with high prevalence of B viral infection and hepatocellular carcinoma. In addition, the Clinical and Molecular Hepatology gives priority to epidemiological studies of hepatobiliary diseases in East Asia, North Asia, Southeast Asia, Central Asia, South Asia, Southwest Asia, Pacific, Africa, Central Europe, Eastern Europe, Central America, and South America.

The Clinical and Molecular Hepatology publishes original papers, meta-analysis, letter to editor, case reports, reviews, guidelines, editorials, and liver image and pathology on all aspects of the field of hepatology.